Serkan Kahyaoglu
Research Subjects
Serkan Kahyaoglu has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Gul Nihal Buyuk
Department of Obstetrics and Gynecology, Ministry of Health Ankara City Hospital, Ankara, Turkey
3 shared publications - Inci Kahyaoglu
Department of Obstetrics and Gynecology, Ankara Etlik City Hospital, Ankara, Türkiye
3 shared publications - İnCi Halilzade
Gynecology and Obstetrics Department, University of Health Sciences Ankara City Hospital, Ankara, Turkey
3 shared publications - Özlem Moraloğlu Tekin
Department of Obstetrics and Gynecology, Ankara Bilkent City Hospital, Ankara, Turkey
3 shared publications - Gülnur Özakşi̇t
Gynecology and Obstetrics Department, University of Health Sciences Ankara City Hospital, Ankara, Turkey
2 shared publications - Meryem Kuru Pekcan
Department of Obstetrics and Gynecology, Zekai Tahir Burak Women's Health Care Training and Research Hospital, Ankara, Turkey
2 shared publications
Latest Publications
- Open Access
- 19 September 2025
- Published by Association of Basic Medical Sciences of FBIH in Biomolecules and Biomedicine
- Vol. 26 (3) , 483-489
Vitamin D deficiency and uterine leiomyoma in unexplained infertility
Uterine leiomyomas are the most common benign tumors of the female genital tract, and alongside hormonal and genetic factors, emerging evidence implicates vitamin D deficiency in their pathogenesis. We investigated the association between serum 25-hydroxyvitamin D [25(OH)D] and the presence of uterine leiomyomas in women with unexplained infertility. In this retrospective case–control study, 148 women aged 18–45 years presenting to the Infertility Clinic of Ankara Bilkent City Hospital between July 2019 and February 2024 were included: 74 had imaging-confirmed leiomyomas (non-submucosal; FIGO types 4–6) and 74 infertile controls had no leiomyomas. Serum 25(OH)D was measured and demographic/clinical data were analyzed with appropriate parametric and non-parametric tests; correlations used Spearman’s rho, and an ANCOVA adjusted for body mass index (BMI) and season assessed group differences. Groups were comparable in age and BMI (e.g., age 35.08 ± 5.79 vs 33.30 ± 5.57 years; p = 0.062). Mean serum 25(OH)D was significantly lower in women with leiomyomas than in controls (41.4 ± 23.7 vs 62.0 ± 34.2 nmol/L; p < 0.001), and this difference remained significant after adjustment for BMI and season (ANCOVA F = 10.7, p = 0.001). Vitamin D levels did not differ by leiomyoma number (single vs multiple: 44.1 ± 21.6 vs 38.5 ± 25.83 nmol/L; p = 0.32) or location (intramural vs subserosal: 40.7 ± 24.9 vs 43.1 ± 21.1 nmol/L; p = 0.69), and were not correlated with leiomyoma size (Spearman r = −0.04; p = 0.70). Among women with unexplained infertility, uterine leiomyomas are thus associated with significantly lower serum 25(OH)D levels, independent of BMI and season, whereas vitamin D status is unrelated to leiomyoma number, size, or location. These findings support a potential role of vitamin D deficiency in leiomyoma pathogenesis and underscore the need for larger, multicenter prospective studies to clarify causality and clinical implications.
- 19 September 2025
- Published by Association of Basic Medical Sciences of FBIH in Biomolecules and Biomedicine
- Vol. 26 (3) , 483-489
Open AccessVitamin D deficiency and uterine leiomyoma in unexplained infertility
Uterine leiomyomas are the most common benign tumors of the female genital tract, and alongside hormonal and genetic factors, emerging evidence implicates vitamin D deficiency in their pathogenesis. We investigated the association between serum 25-hydroxyvitamin D [25(OH)D] and the presence of uterine leiomyomas in women with unexplained infertility. In this retrospective case–control study, 148 women aged 18–45 years presenting to the Infertility Clinic of Ankara Bilkent City Hospital between July 2019 and February 2024 were included: 74 had imaging-confirmed leiomyomas (non-submucosal; FIGO types 4–6) and 74 infertile controls had no leiomyomas. Serum 25(OH)D was measured and demographic/clinical data were analyzed with appropriate parametric and non-parametric tests; correlations used Spearman’s rho, and an ANCOVA adjusted for body mass index (BMI) and season assessed group differences. Groups were comparable in age and BMI (e.g., age 35.08 ± 5.79 vs 33.30 ± 5.57 years; p = 0.062). Mean serum 25(OH)D was significantly lower in women with leiomyomas than in controls (41.4 ± 23.7 vs 62.0 ± 34.2 nmol/L; p < 0.001), and this difference remained significant after adjustment for BMI and season (ANCOVA F = 10.7, p = 0.001). Vitamin D levels did not differ by leiomyoma number (single vs multiple: 44.1 ± 21.6 vs 38.5 ± 25.83 nmol/L; p = 0.32) or location (intramural vs subserosal: 40.7 ± 24.9 vs 43.1 ± 21.1 nmol/L; p = 0.69), and were not correlated with leiomyoma size (Spearman r = −0.04; p = 0.70). Among women with unexplained infertility, uterine leiomyomas are thus associated with significantly lower serum 25(OH)D levels, independent of BMI and season, whereas vitamin D status is unrelated to leiomyoma number, size, or location. These findings support a potential role of vitamin D deficiency in leiomyoma pathogenesis and underscore the need for larger, multicenter prospective studies to clarify causality and clinical implications.
- 31 July 2024
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 168 (1) , 314-319
Value of serum muscular creatinine phosphokinase levels in patients with adenomyosis as a non‐invasive diagnostic marker
Objective: In the present study, we aimed to compare serum CK‐MM levels in patients with and without adenomyosis and to investigate whether CK‐MM level can be a non‐invasive marker for myometrial damage due to adenomyosis.Materials and Methods: Our study was a prospective case‐control study in a tertiary center and consisted of 40 patients with a clinical/ultrasonographic diagnosis of adenomyosis and 40 patients without a clinical/ultrasonographic diagnosis of adenomyosis as the control group based on recently published morphological uterus sonographic assessment (MUSA) criteria. Individuals of similar age who signed a voluntary consent form were included in our study. Demographic, clinical, and laboratory findings of the patients in both groups were recorded. Blood serum samples were used for the determination of serum CK‐MM levels of the participants in our study. The samples were analyzed by using the human CK‐MM enzyme‐linked immunosorbent assay (ELISA) kit.Results: In our study, the mean serum CK‐MM level was 16.2 ± 21.7 (ng/dL) in patients with adenomyosis and 2.6 ± 2.2 (ng/dL) in patients without adenomyosis. Serum CK‐MM level was statistically significantly higher in the patient group with adenomyosis than in the control group (p < 0.001). The CK‐MM threshold value of 3.43 ng/mL, with a sensitivity of 82.5% and specificity of 85%, has been found to be a valuable distinguishing level in patients with and without adenomyosis.Conclusion: In this study, we demonstrated that serum CK‐MM can be used as a non‐invasive diagnostic method in patients with adenomyosis. As the number of studies around this subject in the literature is insufficient, larger studies are needed to use CK‐MM as a diagnostic marker in adenomyosis.
- 31 July 2024
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 168 (1) , 314-319
Value of serum muscular creatinine phosphokinase levels in patients with adenomyosis as a non‐invasive diagnostic marker
Objective: In the present study, we aimed to compare serum CK‐MM levels in patients with and without adenomyosis and to investigate whether CK‐MM level can be a non‐invasive marker for myometrial damage due to adenomyosis.Materials and Methods: Our study was a prospective case‐control study in a tertiary center and consisted of 40 patients with a clinical/ultrasonographic diagnosis of adenomyosis and 40 patients without a clinical/ultrasonographic diagnosis of adenomyosis as the control group based on recently published morphological uterus sonographic assessment (MUSA) criteria. Individuals of similar age who signed a voluntary consent form were included in our study. Demographic, clinical, and laboratory findings of the patients in both groups were recorded. Blood serum samples were used for the determination of serum CK‐MM levels of the participants in our study. The samples were analyzed by using the human CK‐MM enzyme‐linked immunosorbent assay (ELISA) kit.Results: In our study, the mean serum CK‐MM level was 16.2 ± 21.7 (ng/dL) in patients with adenomyosis and 2.6 ± 2.2 (ng/dL) in patients without adenomyosis. Serum CK‐MM level was statistically significantly higher in the patient group with adenomyosis than in the control group (p < 0.001). The CK‐MM threshold value of 3.43 ng/mL, with a sensitivity of 82.5% and specificity of 85%, has been found to be a valuable distinguishing level in patients with and without adenomyosis.Conclusion: In this study, we demonstrated that serum CK‐MM can be used as a non‐invasive diagnostic method in patients with adenomyosis. As the number of studies around this subject in the literature is insufficient, larger studies are needed to use CK‐MM as a diagnostic marker in adenomyosis.
- 28 April 2024
- Published by Ministry of Health, Ankara City Hospital in Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi
Is AMH Really Related to Hyperandrogenism and Insulin Resistance? A Study in Young Women With PCOS
Aims: Polycystic ovary syndrome (PCOS) is an endocrinological disease associated with hyperandrogenism and insulin resistance. Although the place of AMH in polycystic ovary syndrome has been accepted with the recently published guideline, the underlying mechanisms still remain unclear. The aim of this study is to investigate the relationship between hyperandrogenism and AMH using phenotypes A and D in PCOS and to show the place of AMH in the diagnosis of PCOS phenotype without hyperandrogenism. In addition, to reveal the relationship between insulin resistance and AMH. Material and Method: One hundred two patients with PCOS were included in this study. The patients were divided into two groups as Phenotype A and D. In addition, the patients were divided into 2 groups; with (HOMA-IR ≥2.5) and without insulin resistance (IR). The primary outcome was to measure the serum AMH levels between two groups. The secondary outcome was to compare demographic and clinical caracterics (age, BMI, laboratory values). Results: There was no significant difference in AMH values between phenotypes A and D. When patients are divided into 2 groups as PCOS with insulin resistant and without insulin resistant, AMH was found to be significantly lower in the insulin resistant PCOS (p=0.006). The cut-off value for AMH was 6.26 ng/ml, with a sensitivity of 70.4% and a specificity of 62.5%. Conclusion: As a result of our study, we think that the relationship of AMH with hyperandrogenism is not clear and reliable, as it is not a defining indicator between A and D phenotypes in PCOS, but it could be an indicator in determining insülin resistance in PCOS.
- 28 April 2024
- Published by Ministry of Health, Ankara City Hospital in Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi
Is AMH Really Related to Hyperandrogenism and Insulin Resistance? A Study in Young Women With PCOS
Aims: Polycystic ovary syndrome (PCOS) is an endocrinological disease associated with hyperandrogenism and insulin resistance. Although the place of AMH in polycystic ovary syndrome has been accepted with the recently published guideline, the underlying mechanisms still remain unclear. The aim of this study is to investigate the relationship between hyperandrogenism and AMH using phenotypes A and D in PCOS and to show the place of AMH in the diagnosis of PCOS phenotype without hyperandrogenism. In addition, to reveal the relationship between insulin resistance and AMH. Material and Method: One hundred two patients with PCOS were included in this study. The patients were divided into two groups as Phenotype A and D. In addition, the patients were divided into 2 groups; with (HOMA-IR ≥2.5) and without insulin resistance (IR). The primary outcome was to measure the serum AMH levels between two groups. The secondary outcome was to compare demographic and clinical caracterics (age, BMI, laboratory values). Results: There was no significant difference in AMH values between phenotypes A and D. When patients are divided into 2 groups as PCOS with insulin resistant and without insulin resistant, AMH was found to be significantly lower in the insulin resistant PCOS (p=0.006). The cut-off value for AMH was 6.26 ng/ml, with a sensitivity of 70.4% and a specificity of 62.5%. Conclusion: As a result of our study, we think that the relationship of AMH with hyperandrogenism is not clear and reliable, as it is not a defining indicator between A and D phenotypes in PCOS, but it could be an indicator in determining insülin resistance in PCOS.
- 30 July 2023
- Published by Ministry of Health, Ankara City Hospital in Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi
Açıklanamayan İnfertilitede IUI Tedavisinde GND ve Klomifen Sitrat İle Ovulasyon İndüksiyonu İle Gelişen Preovulatuar Folikül Sayısının Gebelik Oranlarına Etkisi
Aim: The aim of this study is to investigate whether the number of dominant follicles formed in IUI with ovarian stimulation (OS) affects pregnancy outcomes in couples with unexplained infertility. Material and Method: 217 couples aged 24-39 years with unexplained infertility and treated with IUI by way of OS participated in our study. The patients were divided into 2 groups of which the first included the clinically pregnant and the second did not, and were compared in terms of age, monofollicle and bifollicle development, infertility duration, treatment initiation day, hcg day, leading follicle diameter, endometrial thickness, number of dominant follicles and treatment type. Results: Of the 217 patients who underwent IUI for unexplained infertility, no significant difference was found between the groups with and without clinical pregnancy in terms of the number of dominant follicles (p=0.73). There was a positive but low correlation between endometrial thickness and treatment success (Spearman's correlation coefficient value = 0.14, p=0.03). The receiver operating characteristic curve analysis revealed that the optimal cut-off value for endometrial thickness to predict pregnancy success was 9.5 mm (55.0% sensitivity, 65.0% specificity). Conclusions: As a result, we suggest that gonadotropins are not superior to oral agents in terms of clinical pregnancy rates in unexplained infertility, therefore treatment should commence with less invasive and less costly oral agents. Furthermore, we think that the number of dominant follicles (monofollicles or bifollicles) created by ovarian stimulation does not affect clinical pregnancy success, but endometrial thickness is closely related to pregnancy rates and deserves attention.
- 30 July 2023
- Published by Ministry of Health, Ankara City Hospital in Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi
Açıklanamayan İnfertilitede IUI Tedavisinde GND ve Klomifen Sitrat İle Ovulasyon İndüksiyonu İle Gelişen Preovulatuar Folikül Sayısının Gebelik Oranlarına Etkisi
Aim: The aim of this study is to investigate whether the number of dominant follicles formed in IUI with ovarian stimulation (OS) affects pregnancy outcomes in couples with unexplained infertility. Material and Method: 217 couples aged 24-39 years with unexplained infertility and treated with IUI by way of OS participated in our study. The patients were divided into 2 groups of which the first included the clinically pregnant and the second did not, and were compared in terms of age, monofollicle and bifollicle development, infertility duration, treatment initiation day, hcg day, leading follicle diameter, endometrial thickness, number of dominant follicles and treatment type. Results: Of the 217 patients who underwent IUI for unexplained infertility, no significant difference was found between the groups with and without clinical pregnancy in terms of the number of dominant follicles (p=0.73). There was a positive but low correlation between endometrial thickness and treatment success (Spearman's correlation coefficient value = 0.14, p=0.03). The receiver operating characteristic curve analysis revealed that the optimal cut-off value for endometrial thickness to predict pregnancy success was 9.5 mm (55.0% sensitivity, 65.0% specificity). Conclusions: As a result, we suggest that gonadotropins are not superior to oral agents in terms of clinical pregnancy rates in unexplained infertility, therefore treatment should commence with less invasive and less costly oral agents. Furthermore, we think that the number of dominant follicles (monofollicles or bifollicles) created by ovarian stimulation does not affect clinical pregnancy success, but endometrial thickness is closely related to pregnancy rates and deserves attention.
- Open Access
- 30 March 2023
- Published by Mebas Medikal Basin Yayin Ltd. Sti in Gynecology Obstetrics & Reproductive Medicine
- p. 1-6
Does Baseline Serum Androgen Levels Have an Impact on Ovulation Induction Cycle Outcomes by Using Clomifene Citrate Among Infertile Women with Polycystic Ovary Syndrome? A Retrospective Cohort Study
OBJECTIVE: Hyperandrogenism is one of the diagnostic criteria for polycystic ovary syndrome. Women with polycystic ovary syndrome suffer from infertility due to anovulation. Hyperandrogenism results in follicular arrest at the antral stage during folliculogenesis. baseline intrinsic hyperandrogenism affects the success of ovulation induction or not. The relationship between baseline serum androgen levels and ovulation induction cycle outcomes by using clomifene citrate among infertile women with polycystic ovary syndrome has not been investigated thoroughly. STUDY DESIGN: Ovulation induction cycle outcomes of 35 infertile women diagnosed with polycystic ovary syndrome according to Rotterdam criteria who have received 50-100 mg/day clomifene citrate have been evaluated retrospectively. Menstrual cycle day 2-5 serum levels for gonadotropins, androgens, metabolic parameters, and ovulation induction cycle outcomes have been compared between women who have and have not achieved clinical pregnancy following treatment. RESULTS: Serum basal follicular stimulating hormone, LH, E2, fasting cholesterol, glucose, and HOMA-IR levels were comparable between these two groups of patients. Unlike other serum androgens, baseline serum-free testosterone level is significantly lower for patients who have achieved clinical pregnancy following ovulation induction with clomifene citrate. The baseline serum cut-off level for free testosterone to predict clinical pregnancy was 1.94 pg/ml with 75% sensitivity and 67% specificity rates. CONCLUSION: Lower or higher levels of androgenic milieu within the ovaries result in defective folliculogenesis and ovulation failure. Increased serum levels of free testosterone which is a proxy for ovarian androgen production might be a detrimental factor for clinical pregnancy rates of women with polycystic ovary syndrome by impairing proper folliculogenesis.
- 30 March 2023
- Published by Mebas Medikal Basin Yayin Ltd. Sti in Gynecology Obstetrics & Reproductive Medicine
- p. 1-6
Open AccessDoes Baseline Serum Androgen Levels Have an Impact on Ovulation Induction Cycle Outcomes by Using Clomifene Citrate Among Infertile Women with Polycystic Ovary Syndrome? A Retrospective Cohort Study
OBJECTIVE: Hyperandrogenism is one of the diagnostic criteria for polycystic ovary syndrome. Women with polycystic ovary syndrome suffer from infertility due to anovulation. Hyperandrogenism results in follicular arrest at the antral stage during folliculogenesis. baseline intrinsic hyperandrogenism affects the success of ovulation induction or not. The relationship between baseline serum androgen levels and ovulation induction cycle outcomes by using clomifene citrate among infertile women with polycystic ovary syndrome has not been investigated thoroughly. STUDY DESIGN: Ovulation induction cycle outcomes of 35 infertile women diagnosed with polycystic ovary syndrome according to Rotterdam criteria who have received 50-100 mg/day clomifene citrate have been evaluated retrospectively. Menstrual cycle day 2-5 serum levels for gonadotropins, androgens, metabolic parameters, and ovulation induction cycle outcomes have been compared between women who have and have not achieved clinical pregnancy following treatment. RESULTS: Serum basal follicular stimulating hormone, LH, E2, fasting cholesterol, glucose, and HOMA-IR levels were comparable between these two groups of patients. Unlike other serum androgens, baseline serum-free testosterone level is significantly lower for patients who have achieved clinical pregnancy following ovulation induction with clomifene citrate. The baseline serum cut-off level for free testosterone to predict clinical pregnancy was 1.94 pg/ml with 75% sensitivity and 67% specificity rates. CONCLUSION: Lower or higher levels of androgenic milieu within the ovaries result in defective folliculogenesis and ovulation failure. Increased serum levels of free testosterone which is a proxy for ovarian androgen production might be a detrimental factor for clinical pregnancy rates of women with polycystic ovary syndrome by impairing proper folliculogenesis.
- Open Access
- 10 December 2022
- Published by Online Turk Saglik Bilimleri Dergisi in Online Türk Sağlık Bilimleri Dergisi
- Vol. 7 (4) , 631-635
Laparoscopic Neovagina Creation by Using Modified Davydov Technique
A-21 year-old woman diagnosed with Meyer Rokitamsky Kuster Hauser syndrome has presented with a complaint of amenorrhea and failure to have vaginal penetration during coitus. On magnetic resonance imaging, bilateral rudimentary uterine remnants next to normal-appearing ovaries with absence of uterus have been detected. Laparoscopically, a 3 cm transverse incision was made pelvic peritoneum and vaginal apex to create a two-finger width opening to the blind vagina. Anterior and posterior visceral peritoneal edges have been grasped and sutured vaginally to the vaginal epithelial border. A continuous purse string stitch technique has been utilized to close the proximal part of the neovagina. The postoperative course of the patient was uneventful. The patient kept using a vaginal silicone dilatator every night for 3 months and she was allowed to have regular coital activity after then. The modified Davydov procedure is an efficient surgical technique with lower complication rates and vaginal stenosis rates.
- 10 December 2022
- Published by Online Turk Saglik Bilimleri Dergisi in Online Türk Sağlık Bilimleri Dergisi
- Vol. 7 (4) , 631-635
Open AccessLaparoscopic Neovagina Creation by Using Modified Davydov Technique
A-21 year-old woman diagnosed with Meyer Rokitamsky Kuster Hauser syndrome has presented with a complaint of amenorrhea and failure to have vaginal penetration during coitus. On magnetic resonance imaging, bilateral rudimentary uterine remnants next to normal-appearing ovaries with absence of uterus have been detected. Laparoscopically, a 3 cm transverse incision was made pelvic peritoneum and vaginal apex to create a two-finger width opening to the blind vagina. Anterior and posterior visceral peritoneal edges have been grasped and sutured vaginally to the vaginal epithelial border. A continuous purse string stitch technique has been utilized to close the proximal part of the neovagina. The postoperative course of the patient was uneventful. The patient kept using a vaginal silicone dilatator every night for 3 months and she was allowed to have regular coital activity after then. The modified Davydov procedure is an efficient surgical technique with lower complication rates and vaginal stenosis rates.
- 31 December 2021
- Published by Turkish Journal of Womens Health and Neonatology, University of Health Sciences in Türk Kadın Sağlığı ve Neonatoloji Dergisi
- Vol. 3 (4) , 99-103
Covid-19 Aşısının Kadın Sağlığı Üzerine Olan Etkileri
Tüm dünyayı etkisi altına alan koronavirus-19 (Covid-19) pandemisini kontrol altına almak amacıyla ilaç ve aşı çalışmaları devam etmektedir. Hastalığın henüz etkin bir ilaç tedavisinin geliştirilememiş olması aşılanmanın önemini arttırmaktadır. Covid-19 aşılarının geliştirilmesi ve ülkelerce yaygın kullanıma girmesi ile beraber ağır hastalık ve ölüm oranları azalmıştır. Yapılan çalışmalar aşıların özellikle ağır hastalığı önlemede etkin ve güvenilir olduğunu ortaya koymuştur. Bu derlememizde Covid-19 aşılarının kadın sağlığı açısından kullanım alanlarını son veriler ışığında değerlendirdik.
- 31 December 2021
- Published by Turkish Journal of Womens Health and Neonatology, University of Health Sciences in Türk Kadın Sağlığı ve Neonatoloji Dergisi
- Vol. 3 (4) , 99-103
Covid-19 Aşısının Kadın Sağlığı Üzerine Olan Etkileri
Tüm dünyayı etkisi altına alan koronavirus-19 (Covid-19) pandemisini kontrol altına almak amacıyla ilaç ve aşı çalışmaları devam etmektedir. Hastalığın henüz etkin bir ilaç tedavisinin geliştirilememiş olması aşılanmanın önemini arttırmaktadır. Covid-19 aşılarının geliştirilmesi ve ülkelerce yaygın kullanıma girmesi ile beraber ağır hastalık ve ölüm oranları azalmıştır. Yapılan çalışmalar aşıların özellikle ağır hastalığı önlemede etkin ve güvenilir olduğunu ortaya koymuştur. Bu derlememizde Covid-19 aşılarının kadın sağlığı açısından kullanım alanlarını son veriler ışığında değerlendirdik.
- Open Access
- 2 August 2021
- Published by Mebas Medikal Basin Yayin Ltd. Sti in Gynecology Obstetrics & Reproductive Medicine
- Vol. 27 (2) , 123-127
Oxytocin Versus Dinoprostone For Labor Induction in Multiparous Women with Unfavorable Cervix
OBJECTIVE: Dinoprostone is a drug of choice in our daily practice for the induction of labor. The aim of our study; to compare the use of oxytocin with dinoprostone (PGE2- Propess©) used in term multiparous pregnant women to ripen the cervix. STUDY DESIGN: A total of 507 patients were included in the study. Group A, consisted of 262 women with term multiparous pregnancy Bishop score ≤6 underwent induction of labor with a vaginal insert containing 10-mg timed-release dinoprostone (Propess© -prostaglandin E2). Group B, consisted of 245 cases of pregnancy with Bishop score ≤6 underwent induction of labor with iv oxytocin and was matched for the patient's age and parity. The following data were recorded: age, gestational age, body mass index, the time from the drug administration to the vaginal labor, delivery mode, indications of induction, cesarean indication, birth weight, Apgar score, and need of neonatal intensive care unit. RESULTS: The primary outcome of the in group B interval from induction to vaginal delivery was similar between the two groups. In group A, 41 patients and in group B, 23 patients had a cesarean section. Cesarean section rate was lower in the oxytocin group (cesarean rate 15.6% versus 9.3%, pCONCLUSION: It appears; Dinoprostone ovule increases the cesarean rate in terms, multiparous cases with inappropriate cervical score and does not shorten the duration of delivery. Therefore, the use of oxytocin for cervical ripening in multiparous women may be a more appropriate option.
- 2 August 2021
- Published by Mebas Medikal Basin Yayin Ltd. Sti in Gynecology Obstetrics & Reproductive Medicine
- Vol. 27 (2) , 123-127
Open AccessOxytocin Versus Dinoprostone For Labor Induction in Multiparous Women with Unfavorable Cervix
OBJECTIVE: Dinoprostone is a drug of choice in our daily practice for the induction of labor. The aim of our study; to compare the use of oxytocin with dinoprostone (PGE2- Propess©) used in term multiparous pregnant women to ripen the cervix. STUDY DESIGN: A total of 507 patients were included in the study. Group A, consisted of 262 women with term multiparous pregnancy Bishop score ≤6 underwent induction of labor with a vaginal insert containing 10-mg timed-release dinoprostone (Propess© -prostaglandin E2). Group B, consisted of 245 cases of pregnancy with Bishop score ≤6 underwent induction of labor with iv oxytocin and was matched for the patient's age and parity. The following data were recorded: age, gestational age, body mass index, the time from the drug administration to the vaginal labor, delivery mode, indications of induction, cesarean indication, birth weight, Apgar score, and need of neonatal intensive care unit. RESULTS: The primary outcome of the in group B interval from induction to vaginal delivery was similar between the two groups. In group A, 41 patients and in group B, 23 patients had a cesarean section. Cesarean section rate was lower in the oxytocin group (cesarean rate 15.6% versus 9.3%, pCONCLUSION: It appears; Dinoprostone ovule increases the cesarean rate in terms, multiparous cases with inappropriate cervical score and does not shorten the duration of delivery. Therefore, the use of oxytocin for cervical ripening in multiparous women may be a more appropriate option.
- Open Access
- 2 December 2019
- Published by Mebas Medikal Basin Yayin Ltd. Sti in Gynecology Obstetrics & Reproductive Medicine
- Vol. 25 (3) , 153-157
Can Testicular Size Be a Predictive Factor for Successful Sperm Retrieval in Patients with Non Obstructive Azoospermia?
Objective: Non-obstructive azoospermia, defined as absence of spermatozoa in the ejaculate caused by impaired spermatogenesis, is the most severe cause of male infertility. It is typically presented as high serum follicle stimulating hormone levels and atrophic testis. The combination of intracytoplasmic sperm injection and Microdissection testicular sperm extraction allows these infertile men the opportunity to have their own children from their own testis. Our aim was to evaluate the outcomes of micro-Testicular sperm extraction in men with atrophic testis.Study Design: The medical records of 80 non-obstructive men with azoospermia who underwent micro-TESE were retrospectively evaluated. We assessed clinical parameters; age, duration of infertility, smoking, chromosomal karyotype, Y chromosome microdeletion, follicle stimulating hormone, luteinizing hormone, total testosterone and testicular volume in relation with Microdissection testicular sperm extraction results.Results: Testicular sperm retrieval rate was 53% in 80 patients. Testicular volume, serum follicle stimulating hormone and total testosterone concentrations showed correlation with the results of sperm retrieval. These three parameters were found to be significant risk factors with testicular sperm extraction negative patients (p<0.001). The odds ratios (95% CI) were 6.39 (1.25–26.58), 1.24 (1.11-1.36), 1.13 (0.99-1.21) respectively. Testicular volume was found to be a discriminative parameter in patients with negative sperm retrieval. The cut-off point was established as 6.75 ml for testicular volume with 88.1% sensitivity, 62.1% specificity.Conclusion: Microdissection testicular sperm extraction is the most effective procedure for patients with non-obstructive azoospermia. Testicular volume, serum follicle stimulating hormone and testosterone levels can be predictive factors for sperm retrieval in men with non-obstructive azoospermia.
- 2 December 2019
- Published by Mebas Medikal Basin Yayin Ltd. Sti in Gynecology Obstetrics & Reproductive Medicine
- Vol. 25 (3) , 153-157
Open AccessCan Testicular Size Be a Predictive Factor for Successful Sperm Retrieval in Patients with Non Obstructive Azoospermia?
Objective: Non-obstructive azoospermia, defined as absence of spermatozoa in the ejaculate caused by impaired spermatogenesis, is the most severe cause of male infertility. It is typically presented as high serum follicle stimulating hormone levels and atrophic testis. The combination of intracytoplasmic sperm injection and Microdissection testicular sperm extraction allows these infertile men the opportunity to have their own children from their own testis. Our aim was to evaluate the outcomes of micro-Testicular sperm extraction in men with atrophic testis.Study Design: The medical records of 80 non-obstructive men with azoospermia who underwent micro-TESE were retrospectively evaluated. We assessed clinical parameters; age, duration of infertility, smoking, chromosomal karyotype, Y chromosome microdeletion, follicle stimulating hormone, luteinizing hormone, total testosterone and testicular volume in relation with Microdissection testicular sperm extraction results.Results: Testicular sperm retrieval rate was 53% in 80 patients. Testicular volume, serum follicle stimulating hormone and total testosterone concentrations showed correlation with the results of sperm retrieval. These three parameters were found to be significant risk factors with testicular sperm extraction negative patients (p<0.001). The odds ratios (95% CI) were 6.39 (1.25–26.58), 1.24 (1.11-1.36), 1.13 (0.99-1.21) respectively. Testicular volume was found to be a discriminative parameter in patients with negative sperm retrieval. The cut-off point was established as 6.75 ml for testicular volume with 88.1% sensitivity, 62.1% specificity.Conclusion: Microdissection testicular sperm extraction is the most effective procedure for patients with non-obstructive azoospermia. Testicular volume, serum follicle stimulating hormone and testosterone levels can be predictive factors for sperm retrieval in men with non-obstructive azoospermia.
- Open Access
- 30 April 2019
- Published by Mebas Medikal Basin Yayin Ltd. Sti in Gynecology Obstetrics & Reproductive Medicine
- Vol. 25 (1) , 18-21
Immersion in Water During Active Labor Decreases Postpartum Hematocrit Fall Following Vaginal Delivery
OBJECTIVE: The objective of the study was to investigate the effect of immersion in water strategy during labor on postpartum bleeding by calculating the postpartum reduction rates of the hematocrit values of the patients.STUDY DESIGN: The study groups consisted of 84 women undergoing vaginal delivery with immersion in water during labor (group 1) and the control group (group 2) of 84 women undergoing normal vaginal delivery. Patients who have received additional medical and surgical interventions for alleviation of postpartum hemorrhage, patients who have undergone an episiotomy and/or perineal trauma were not included in the study. All data were taken from patients who have delivered with spontaneous vaginal delivery. Postpartum hematocrit fall rates of the groups have been compared and the effect of immersion in water on postpartum hemorrhage has been evaluated.RESULTS: The study groups consisted of 84 women undergoing vaginal delivery with immersion in water during labor (Group 1) and the control group (Group 2) of 84 women undergoing vaginal delivery at the hospital. The women in the two groups were matched with respect to age, parity, birth weight and gestational age. The mean age of the women was 29.8±4.8 and 30.5±4.9 respectively. The mean hematocrit difference in the first group was 2.08 ± 1.88 and in the second group was 3.81 ± 1.55. The mean percentage of hematocrit reduction in the first group was 5.71% and in the second group 10.23%.CONCLUSION: Our data showed that mean hematocrit level decreases among women following vaginal delivery more than women who give birth vaginally within immersion in water during labor. The percentage of hematocrit reduction in the water birth group was lower than in the control group. Water birth seems to facilitate uterine contractions more efficiently following vaginal delivery.
- 30 April 2019
- Published by Mebas Medikal Basin Yayin Ltd. Sti in Gynecology Obstetrics & Reproductive Medicine
- Vol. 25 (1) , 18-21
Open AccessImmersion in Water During Active Labor Decreases Postpartum Hematocrit Fall Following Vaginal Delivery
OBJECTIVE: The objective of the study was to investigate the effect of immersion in water strategy during labor on postpartum bleeding by calculating the postpartum reduction rates of the hematocrit values of the patients.STUDY DESIGN: The study groups consisted of 84 women undergoing vaginal delivery with immersion in water during labor (group 1) and the control group (group 2) of 84 women undergoing normal vaginal delivery. Patients who have received additional medical and surgical interventions for alleviation of postpartum hemorrhage, patients who have undergone an episiotomy and/or perineal trauma were not included in the study. All data were taken from patients who have delivered with spontaneous vaginal delivery. Postpartum hematocrit fall rates of the groups have been compared and the effect of immersion in water on postpartum hemorrhage has been evaluated.RESULTS: The study groups consisted of 84 women undergoing vaginal delivery with immersion in water during labor (Group 1) and the control group (Group 2) of 84 women undergoing vaginal delivery at the hospital. The women in the two groups were matched with respect to age, parity, birth weight and gestational age. The mean age of the women was 29.8±4.8 and 30.5±4.9 respectively. The mean hematocrit difference in the first group was 2.08 ± 1.88 and in the second group was 3.81 ± 1.55. The mean percentage of hematocrit reduction in the first group was 5.71% and in the second group 10.23%.CONCLUSION: Our data showed that mean hematocrit level decreases among women following vaginal delivery more than women who give birth vaginally within immersion in water during labor. The percentage of hematocrit reduction in the water birth group was lower than in the control group. Water birth seems to facilitate uterine contractions more efficiently following vaginal delivery.